Within the realm of targeted therapy, certain medications act by inhibiting factors contributing to vascular formation, such as platelet-derived growth factor and vascular endothelial growth factor, thereby disrupting tumor angiogenesis31. The gene discussed is VEGFA; the disease is neoplasm.